Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Fassas

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Clinical Lymphoma|July 3, 2003
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survivalMaurizio Zangari, Bart Barlogie, Raymond Thertulien, et al.
Human Gene Therapy|October 3, 2009
Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemiaEvangelia Yannaki, Nikoleta Psatha, Evangelia Athanasiou, et al.
Molecular Medicine (Cambridge, Mass.)|February 12, 2005
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphomaKostas Stamatopoulos, Chrysoula Belessi, Theodora Papadaki, et al.
Blood|December 3, 2005
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapiesBart Barlogie, Guido Tricot, Erik Rasmussen, et al.
Blood Cells, Molecules & Diseases|July 16, 2008
Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptorsIoanna Chiotoglou, Tatjana Smilevska, Maria Samara, et al.
British Journal of Haematology|August 26, 2004
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationMaurizio Zangari, Bart Barlogie, Elias Anaissie, et al.
Haematologica|September 24, 2009
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune DiseasesDominique Farge, Myriam Labopin, Alan Tyndall, et al.
Experimental Hematology|January 25, 2003
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioningChoon Kee Lee, Ashraf Badros, Bart Barlogie, et al.
Blood|October 7, 2004
Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 genePaolo Ghia, Kostas Stamatopoulos, Chrysoula Belessi, et al.
Blood|August 4, 2005
Immunoglobulin light chain repertoire in chronic lymphocytic leukemiaKostas Stamatopoulos, Chrysoula Belessi, Anastasia Hadzidimitriou, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Clinical Lymphoma|July 3, 2003
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survivalMaurizio Zangari, Bart Barlogie, Raymond Thertulien, et al.
Human Gene Therapy|October 3, 2009
Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemiaEvangelia Yannaki, Nikoleta Psatha, Evangelia Athanasiou, et al.
Molecular Medicine (Cambridge, Mass.)|February 12, 2005
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphomaKostas Stamatopoulos, Chrysoula Belessi, Theodora Papadaki, et al.
Blood|December 3, 2005
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapiesBart Barlogie, Guido Tricot, Erik Rasmussen, et al.
Blood Cells, Molecules & Diseases|July 16, 2008
Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptorsIoanna Chiotoglou, Tatjana Smilevska, Maria Samara, et al.
British Journal of Haematology|August 26, 2004
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationMaurizio Zangari, Bart Barlogie, Elias Anaissie, et al.
Haematologica|September 24, 2009
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune DiseasesDominique Farge, Myriam Labopin, Alan Tyndall, et al.
Experimental Hematology|January 25, 2003
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioningChoon Kee Lee, Ashraf Badros, Bart Barlogie, et al.
Blood|October 7, 2004
Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 genePaolo Ghia, Kostas Stamatopoulos, Chrysoula Belessi, et al.
Blood|August 4, 2005
Immunoglobulin light chain repertoire in chronic lymphocytic leukemiaKostas Stamatopoulos, Chrysoula Belessi, Anastasia Hadzidimitriou, et al.
Pageof 6